Open AccessPB1831: UTILITY OF FLT3 INHIBITORS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND T(6;9)(P22;Q34)
Author(s) -
Ong F.,
Kadia T. M.,
Short N. J.,
Yilmaz M.,
Alvarado Y.,
Pierce S.,
GarciaManero G.,
DiNardo C.,
Borthakur G.,
Konopleva M.,
Daver N.,
Kantarjian H.,
Ravandi F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850176.50038.b1
Subject(s) - medicine , regimen , myeloid leukemia , refractory (planetary science) , cohort , chemotherapy regimen , oncology , gastroenterology , chemotherapy , biology , astrobiology